Ads
related to: desmopressin mechanism of action hemophilia- FAQs
Get Answers To Frequently Asked
Questions About Hemophilia A
- Financial Assistance
Learn More About The Financial
Resources Available To You
- Get One-On-One Support
Connect With An Account & Community
Manager For Hemophilia Support
- Patient Stories
Hear Unique Stories and Experiences
From Real Hemophilia A Patients
- FAQs
Search results
Results From The WOW.Com Content Network
Desmopressin, sold under the trade name DDAVP among others, is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels. [1] In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases. [ 1 ]
2157 14069 Ensembl ENSG00000185010 ENSMUSG00000031196 UniProt P00451 Q06194 RefSeq (mRNA) NM_000132 NM_019863 NM_001161373 NM_001161374 NM_007977 RefSeq (protein) NP_000123 NP_063916 NP_001154845 NP_001154846 NP_032003 Location (UCSC) Chr X: 154.84 – 155.03 Mb Chr X: 74.22 – 74.43 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Coagulation factor VIII (Factor VIII, FVIII, also ...
Because von Willebrand factor helps stabilize circulating levels of factor VIII, the vasopressin analog desmopressin can be used to stimulate the AVPR2 receptor and increase levels of circulating factor VIII. This is useful in the treatment of hemophilia A as well as Von Willebrand disease.
They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.
The most prominent vasopressin analogues include desmopressin (dDAVP), terlipressin, and selepressin, each with distinct pharmacological profiles and clinical uses.. Desmopressin, a V2 receptor agonist, is primarily used for treating diabetes insipidus and certain bleeding diso
The medication desmopressin may be used in those with mild haemophilia A. [16] Gewne therapy treatment was in clinical trials as of 2022, with some approaches and products having received conditional approval. [17] Haemophilia A affects about 1 in 5,000–10,000, while haemophilia B affects about 1 in 40,000 males at birth.
Ads
related to: desmopressin mechanism of action hemophilia